GO:0004707 MAP kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004707 defines MAP kinase activity, a protein kinase molecular function that phosphorylates protein substrates on serine or threonine residues, often within a PXT/SP motif.
• MAP kinases are activated by dual phosphorylation on a conserved T-X-Y motif within their activation loop, catalyzed by upstream MAP2Ks such as MEK1/2 or MKK3/6.
• The family includes ERK1/2, p38 MAPKs, JNKs, and ERK5, which relay signals from the plasma membrane to the nucleus and other compartments.
• Dual-specificity phosphatases (DUSPs) and protein phosphatases tightly regulate MAP kinase activity, preventing aberrant signaling.
• Dysregulated MAP kinase activity contributes to cancer, metabolic disorders, and neuronal apoptosis, making it a major drug target.
• CRISPR knockout, point-mutation knock-in, and overexpression models are essential to dissect MAP kinase gene function in disease and development.
Description
MAP kinase activity (GO:0004707) is a molecular function that catalyzes the phosphorylation of protein substrates on serine or threonine residues, using ATP as the phosphate donor. This activity is central to intracellular signal transduction, converting extracellular cues such as growth factors, hormones, and stress stimuli into cellular responses including proliferation, differentiation, and apoptosis. The MAP kinase family comprises several subfamilies, notably ERK1/2, p38 MAP kinases, JNKs, and ERK5, each with distinct upstream activators and substrate specificities. Researchers study MAP kinase activity to understand how cells interpret environmental signals and how misregulation leads to diseases such as cancer and neurodegeneration. The QuickGO definition emphasizes that these kinases are strongly activated by polypeptide growth factors and tumor-promoting phorbol esters, but weakly by stress stimuli in most cell backgrounds. This article provides a comprehensive overview of the ontology, mechanism, key genes, disease relevance, and CRISPR-based research methods for MAP kinase activity.
MAP kinase activity At A Glance
| GO ID | GO:0004707 |
|---|---|
| GO term | MAP kinase activity |
| Ontology | molecular_function |
| Synonym | ERK, ERK1, ERK2, extracellular signal-regulated kinase activity, MAPK, SAPK, stress-activated protein kinase activity |
| Major function | Phosphorylation of protein substrates on serine/threonine residues, relaying signals from plasma membrane to nucleus |
| Activation mechanism | Dual phosphorylation on T-X-Y motif by upstream MAP2Ks (e.g., MEK1/2, MKK3/6) |
| Substrate examples | Myelin basic protein (MBP), transcription factors (e.g., Elk-1), other kinases |
| Regulation | Dephosphorylation by dual-specificity phosphatases (DUSPs) and protein phosphatases |
| Cellular roles | Proliferation, differentiation, stress response, apoptosis, cytokine production |
What Is GO:0004707?
MAP kinase activity is the catalysis of protein phosphorylation, where a MAP kinase transfers a phosphate group from ATP to a serine or threonine residue on a target protein. This reaction is a crucial step in relaying signals from the plasma membrane to the nucleus, and it is activated by a wide range of proliferation- or differentiation-inducing signals. The activity is typically measured using myelin basic protein (MBP) as a substrate, hence synonyms such as MBP kinase I/II activity.
Why Is MAP kinase activity Important in Cell Biology?
MAP kinase activity is essential for converting extracellular signals into appropriate cellular responses, and its dysregulation is implicated in a wide array of human diseases, including cancer, inflammatory disorders, and neurodegenerative conditions. Understanding the precise molecular mechanisms, regulatory networks, and substrate specificities of MAP kinases is critical for developing targeted therapies and for interpreting genomic data in disease research.
• MAP kinase activity is a central node in signal transduction pathways controlling cell growth, differentiation, and survival.
• Dysregulated MAP kinase signaling is a hallmark of many cancers, including signet-ring cell carcinoma and melanoma.
• p38 MAP kinase activity mediates neuronal apoptosis in response to nitric oxide, linking it to neurodegeneration.
• MAP kinases regulate metabolic processes in skeletal muscle, influencing whole-body energy homeostasis.
• Dual-specificity phosphatases (DUSPs) provide negative feedback that shapes the intensity and duration of MAP kinase signals.
• The p38 pathway controls locomotor activity via IL-15 in muscle, highlighting its role in exercise physiology.
• MAP kinase activity is required for proper immune responses and cytokine production, making it relevant to inflammation.
• Osmostress enhances activating phosphorylation of Hog1 MAP kinase, demonstrating conserved stress-responsive functions.
• Oncogenic Tpl-2 activates MEK-1 and SEK-1, illustrating how upstream kinases can constitutively activate MAP kinase pathways.
• CRISPR-based models enable precise dissection of MAP kinase gene function in health and disease.
Molecular Mechanism and Cellular Roles of MAP kinase activity
Activation by Upstream MAP2Ks
In simple terms: MAP kinases are switched on when another kinase adds two phosphate groups to a specific loop in their structure.
MAP kinases are activated by dual phosphorylation on a conserved threonine and tyrosine residue within their activation loop (T-X-Y motif). This phosphorylation is catalyzed by upstream MAP kinase kinases (MAP2Ks), such as MEK1/2 for ERK1/2, MKK3/6 for p38, and MKK4/7 for JNKs. The MAP2Ks themselves are activated by MAP kinase kinase kinases (MAP3Ks), which respond to diverse stimuli including growth factors, cytokines, and stress. For example, the Tpl-2 proto-oncoprotein activates MEK-1 and SEK-1, leading to downstream MAP kinase activation. In yeast, osmostress enhances activating phosphorylation of Hog1 MAP kinase by mono-phosphorylated Pbs2 MAP2K, demonstrating a conserved mechanism.
Substrate Recognition and Phosphorylation
In simple terms: Once active, MAP kinases recognize and phosphorylate target proteins on specific serine or threonine residues.
Active MAP kinases phosphorylate substrates on serine or threonine residues, often within a consensus motif (PXT/SP for ERK1/2). Substrates include transcription factors (e.g., Elk-1), other kinases (e.g., MAPKAP kinase 2), and structural proteins. The reaction requires ATP as a phosphate donor and magnesium ions as cofactors. Myelin basic protein (MBP) is a commonly used exogenous substrate for measuring MAP kinase activity in vitro. The specificity of substrate phosphorylation is determined by docking interactions between the MAP kinase and its substrates, mediated by conserved docking domains.
Signal Relay from Membrane to Nucleus
In simple terms: MAP kinases carry signals from the cell surface to the nucleus, where they change gene expression.
MAP kinase activity is a crucial step in relaying signals from the plasma membrane to the nucleus. Upon activation, MAP kinases can translocate to the nucleus and phosphorylate transcription factors, thereby altering gene expression programs that control proliferation, differentiation, and apoptosis. For instance, p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons, linking cytoplasmic signaling to mitochondrial cell death machinery. In skeletal muscle, MAP kinase pathway activity is regulated in vivo, affecting metabolic gene expression.
Negative Regulation by Phosphatases
In simple terms: Phosphatases remove phosphate groups from MAP kinases to turn off the signal.
Dual-specificity protein phosphatases (DUSPs) dephosphorylate both threonine and tyrosine residues in the activation loop of MAP kinases, thereby terminating the signal. This negative regulation is critical for preventing sustained MAP kinase activity, which can lead to oncogenic transformation. Different DUSPs exhibit specificity for distinct MAP kinase subfamilies, providing fine-tuned control. Additionally, protein phosphatases such as PP2A can dephosphorylate MAP kinases or their substrates.
Subcellular Localization and Scaffolding
In simple terms: Scaffold proteins hold MAP kinase components together to ensure efficient and specific signaling.
MAP kinase signaling is organized by scaffold proteins (e.g., KSR, JIP) that assemble MAP3K, MAP2K, and MAPK into functional modules, enhancing signaling efficiency and specificity. MAP kinases localize to various cellular compartments, including the cytoplasm, nucleus, and mitochondria, depending on the subfamily and context. For example, p38 MAP kinase translocates to mitochondria during apoptosis to mediate bax translocation. This spatial regulation is essential for proper signal transduction.
Key Genes Involved in GO:0004707 MAP kinase activity
The following genes encode proteins that either are MAP kinases or directly regulate MAP kinase activity, and they are frequently studied using CRISPR-based approaches.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MAPK1 (ERK2) | Serine/threonine kinase in ERK1/2 pathway | Cell proliferation, cancer, drug resistance |
| MAPK3 (ERK1) | Serine/threonine kinase in ERK1/2 pathway | Cell cycle regulation, neuronal plasticity |
| MAPK14 (p38α) | Stress-activated MAP kinase | Inflammation, apoptosis, neurodegeneration |
| MAPK11 (p38β) | Stress-activated MAP kinase | Cytokine production, cardiac hypertrophy |
| MAPK8 (JNK1) | Stress-activated MAP kinase | Apoptosis, insulin resistance, immune response |
| MAPK9 (JNK2) | Stress-activated MAP kinase | T cell differentiation, cancer |
| MAPK7 (ERK5) | Atypical MAP kinase | Cardiovascular development, angiogenesis |
| MAP2K1 (MEK1) | Upstream kinase activating ERK1/2 | Melanoma, therapeutic target |
| MAP2K2 (MEK2) | Upstream kinase activating ERK1/2 | Cancer, RASopathies |
| MAP2K3 (MKK3) | Upstream kinase activating p38 | Inflammation, stress response |
| MAP2K6 (MKK6) | Upstream kinase activating p38 | Apoptosis, cytokine signaling |
| MAP3K1 (MEKK1) | MAP kinase kinase kinase | JNK/p38 activation, cancer |
| MAP3K8 (Tpl-2) | MAP kinase kinase kinase | Oncogenesis, immune regulation |
| DUSP1 (MKP-1) | Dual-specificity phosphatase | Negative regulation of MAPKs, cancer |
| DUSP6 (MKP-3) | Dual-specificity phosphatase | ERK1/2 inactivation, development |
| MAPKAPK2 | Downstream kinase of p38 | Cytokine production, stress response |
| ELK1 | Transcription factor substrate of ERK | Immediate early gene expression, cancer |
How Is MAP kinase activity Regulated?
MAP kinase activity is regulated at multiple levels. Upstream MAP3Ks and MAP2Ks activate MAP kinases through phosphorylation. Dual-specificity phosphatases (DUSPs) and protein phosphatases dephosphorylate and inactivate MAP kinases. Scaffold proteins modulate the efficiency and specificity of signaling complexes. Additionally, cross-talk with other pathways, such as the PI 3-kinase-Rac-p38 MAP kinase pathway, can influence MAP kinase activity in specific contexts. In skeletal muscle, MAP kinase pathway activity is regulated in vivo by exercise and hormonal signals. The p38 signaling in muscle controls locomotor activity via IL-15, demonstrating physiological regulation.
MAP kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MAPK1 | Cancer (melanoma, colorectal) | Knockout and point-mutation knock-in in cancer cell lines |
| MAPK14 | Neurodegeneration, inflammation | Conditional knockout in neurons or macrophages |
| MAP2K1 | Melanoma, RASopathies | Knock-in of activating mutations (e.g., V600E) in melanoma cells |
| DUSP1 | Cancer, metabolic syndrome | Overexpression and knockout in hepatocytes or adipocytes |
| MAPK8 | Insulin resistance, neurodegeneration | Tissue-specific knockout in muscle or brain |
MAP Kinase Activity in Cancer
Dysregulated MAP kinase activity is a hallmark of many cancers. Activating mutations in upstream components such as RAS or BRAF lead to constitutive ERK1/2 activation, driving proliferation and survival. The PI 3-kinase-Rac-p38 MAP kinase pathway is involved in the formation of signet-ring cell carcinoma, a highly aggressive gastric cancer subtype. Overexpression or hyperactivation of MAP kinases can promote epithelial-mesenchymal transition and metastasis. Targeting MAP kinase activity with small molecule inhibitors (e.g., MEK inhibitors) has shown clinical benefit in melanoma and other cancers.
MAP Kinase Activity in Neurodegeneration
p38 MAP kinase activity mediates bax translocation in nitric oxide-induced apoptosis in neurons, implicating it in neurodegenerative diseases such as Parkinson's and Alzheimer's. Sustained JNK activation contributes to neuronal death in ischemia and excitotoxicity. Conversely, ERK1/2 signaling supports neuronal survival and plasticity, and its dysregulation is linked to cognitive disorders. Modulating MAP kinase activity is therefore a potential therapeutic strategy for neuroprotection.
MAP Kinase Activity in Metabolic and Inflammatory Disorders
MAP kinase pathway activity in skeletal muscle is regulated in vivo and influences glucose uptake and energy metabolism. p38 signaling in muscle controls locomotor activity via IL-15, linking MAP kinases to exercise capacity and metabolic health. In inflammation, p38 and JNK pathways regulate cytokine production, and their inhibition is being explored for autoimmune diseases. Dual-specificity phosphatases that inactivate MAP kinases are also implicated in metabolic syndrome and obesity.
From MAP kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of MAPK1 inhibit tumor growth? | CRISPR knockout of MAPK1 in cancer cell lines and xenografts |
| How does a specific MAPK mutation affect kinase activity? | Point-mutation knock-in of catalytic or regulatory residues |
| What is the effect of MAPK fusion proteins? | Knock-in of chromosomal translocation-derived fusion genes |
| Where is MAPK localized in live cells? | Tagged knock-in with fluorescent protein (e.g., GFP) at endogenous locus |
| Does overexpression of DUSP1 rescue MAPK hyperactivation? | Overexpression of DUSP1 in MAPK-driven cancer models |
| Can CRISPR library screening identify synthetic lethal partners? | Genome-wide CRISPR knockout library screening in MAPK-mutant cells |
How to Study the MAP kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro kinase assay | Phosphorylation of MBP or peptide substrates | Measuring MAP kinase activity in cell lysates |
| Western blot with phospho-antibodies | Activation loop phosphorylation (T-X-Y) | Assessing MAP kinase activation status |
| RNA-seq | Global gene expression changes | Identifying downstream transcriptional programs |
| Phosphoproteomics | Phosphorylation sites on proteins | Discovering novel MAP kinase substrates |
| Live-cell imaging | Subcellular localization and dynamics | Tracking MAP kinase translocation in real time |
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Identifying modifiers of MAPK inhibitor sensitivity |
| Bioinformatics pathway analysis | Enrichment of signaling pathways | Interpreting omics data in MAPK context |
Kinase Activity Assays
MAP kinase activity is routinely measured using in vitro kinase assays with myelin basic protein (MBP) as a substrate and [γ-32P]ATP. Alternatively, phospho-specific antibodies against the T-X-Y motif of MAP kinases are used in Western blotting to assess activation status. These methods are fundamental for validating CRISPR models and drug responses.
Transcriptomics and Proteomics
RNA sequencing (RNA-seq) can reveal changes in gene expression programs downstream of MAP kinase activity, such as immediate early genes. Phosphoproteomics using mass spectrometry identifies direct substrates and signaling networks regulated by MAP kinases. These approaches are powerful when combined with CRISPR knockout or knock-in models to link genotype to phenotype.
Imaging and Localization Studies
Fluorescence microscopy of tagged MAP kinases (e.g., GFP knock-in) allows real-time visualization of subcellular localization and translocation. Live-cell imaging can track MAP kinase dynamics in response to stimuli, providing spatial and temporal resolution. This is particularly useful for studying p38 translocation to mitochondria during apoptosis.
CRISPR Library Screening and Bioinformatics
Genome-wide CRISPR knockout or activation screens can identify genes that modulate MAP kinase activity or that are synthetic lethal with MAPK mutations. Bioinformatics analysis of screen data, including pathway enrichment and network modeling, helps prioritize hits and generate hypotheses. These methods accelerate target discovery in MAPK-driven diseases.
How CRISPR Can Be Used to Study GO:0004707 MAP kinase activity
Knockout
CRISPR knockout of MAP kinase genes (e.g., MAPK1, MAPK14) enables loss-of-function studies to determine their role in proliferation, apoptosis, and differentiation. Knockout cell lines are valuable for validating drug targets and for identifying compensatory pathways. For example, MAPK14 knockout in neurons can protect against nitric oxide-induced apoptosis.
Point Mutation
Point-mutation knock-in using CRISPR can introduce specific amino acid substitutions (e.g., catalytic dead mutants or phosphorylation-site mutants) to dissect MAP kinase function. This approach is ideal for studying activating mutations found in cancer, such as MAP2K1 mutations. It allows precise structure-function analysis without confounding effects of complete gene loss.
Knock-in
Knock-in of reporter tags (e.g., GFP, luciferase) or fusion proteins at endogenous MAP kinase loci enables real-time tracking of expression and localization. Knock-in of disease-associated mutations (e.g., MAPK fusions) creates physiologically relevant models for drug testing. CRISPR-mediated knock-in is also used to generate conditional alleles for tissue-specific studies.
Overexpression
Overexpression of wild-type or mutant MAP kinases (e.g., constitutively active MEK1) via CRISPR-mediated integration or lentiviral delivery can model hyperactivation states observed in cancer. Overexpression of negative regulators like DUSP1 can rescue MAPK hyperactivation and is useful for validating regulatory mechanisms. These models complement knockout studies by providing gain-of-function insights.
How EDITGENE Supports MAP kinase activity Research
Researchers studying MAP kinase activity-related genes often need to determine whether a candidate gene is causally involved in a specific signaling output, disease phenotype, or drug response. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models that answer these questions with high confidence.
Contact EDITGENE today to design your custom CRISPR model for MAP kinase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| MAP3K7 Knockout HEK293 Cell Line | EDJ-KQ142 | Human | 6885 | Details Get a Quote |
| MAPK8 Knockout HEK293 Cell Line | EDJ-KQ193 | Human | 5599 | Details Get a Quote |
| MAPK1 Knockout HEK293 Cell Line | EDJ-KQ390 | Human | 5594 | Details Get a Quote |
| MAPK3 Knockout HEK293 Cell Line | EDJ-KQ391 | Human | 5595 | Details Get a Quote |
| MAPK10 Knockout HEK293 Cell Line | EDJ-KQ697 | Human | 5602 | Details Get a Quote |
| MAPK11 Knockout HEK293 Cell Line | EDJ-KQ698 | Human | 5600 | Details Get a Quote |
| MAPK13 Knockout HEK293 Cell Line | EDJ-KQ699 | Human | 5603 | Details Get a Quote |
| MAPK14 Knockout HEK293 Cell Line | EDJ-KQ700 | Human | 1432 | Details Get a Quote |
| MAPK7 Knockout HEK293 Cell Line | EDJ-KQ701 | Human | 5598 | Details Get a Quote |
| MAPK9 Knockout HEK293 Cell Line | EDJ-KQ705 | Human | 5601 | Details Get a Quote |
| NLK Knockout HEK293 Cell Line | EDJ-KQ716 | Human | 51701 | Details Get a Quote |
| MAPK12 Knockout HEK293 Cell Line | EDJ-KQ1354 | Human | 6300 | Details Get a Quote |
| CDK16 Knockout HEK293 Cell Line | EDJ-KQ2177 | Human | 5127 | Details Get a Quote |
| MAPK4 Knockout HEK293 Cell Line | EDJ-KQ5538 | Human | 5596 | Details Get a Quote |
| MAPK15 Knockout HEK293 Cell Line | EDJ-KQ9257 | Human | 225689 | Details Get a Quote |
Displaying Records 1 To 15 Of 71 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About MAP kinase activity
What is MAP kinase activity?
MAP kinase activity (GO:0004707) is a molecular function where a MAP kinase enzyme phosphorylates protein substrates on serine or threonine residues, using ATP as a phosphate donor, to relay signals from the cell surface to the nucleus.
What genes are involved in MAP kinase activity?
Key genes include MAPK1 (ERK2), MAPK3 (ERK1), MAPK14 (p38α), MAPK8 (JNK1), MAP2K1 (MEK1), MAP2K3 (MKK3), and DUSP1 (MKP-1), among others.
How is MAP kinase activity regulated?
It is activated by dual phosphorylation via upstream MAP2Ks and inactivated by dual-specificity phosphatases (DUSPs) and protein phosphatases.
What diseases are associated with MAP kinase activity?
Dysregulated MAP kinase activity is linked to cancer, neurodegeneration, inflammatory disorders, and metabolic diseases.
What is the role of p38 MAP kinase in apoptosis?
p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons, linking stress signaling to mitochondrial cell death.
How can I study MAP kinase activity in the lab?
Common methods include in vitro kinase assays with MBP, Western blotting with phospho-specific antibodies, RNA-seq, phosphoproteomics, and CRISPR-based knockout or knock-in models.
What is the difference between ERK, JNK, and p38 MAP kinases?
They are distinct subfamilies with different upstream activators and substrate specificities: ERK1/2 responds to growth factors, while JNK and p38 are stress-activated.
Can CRISPR be used to study MAP kinase function?
Yes, CRISPR knockout, point-mutation knock-in, and overexpression models are widely used to dissect MAP kinase gene function in health and disease.
What is the role of DUSPs in MAP kinase signaling?
Dual-specificity phosphatases (DUSPs) dephosphorylate MAP kinases, providing negative feedback and preventing sustained signaling that can lead to cancer.
How does MAP kinase activity affect skeletal muscle?
MAP kinase pathway activity in skeletal muscle is regulated in vivo and influences metabolism and locomotor activity via IL-15.
Conclusion
MAP kinase activity (GO:0004707) is a fundamental molecular function that orchestrates cellular responses to a myriad of external signals. Its dysregulation underlies numerous human diseases, making it a prime target for therapeutic intervention and research. Understanding the precise mechanisms, key genes, and regulatory networks of MAP kinases requires robust experimental models. CRISPR-based approaches, including knockout, point-mutation knock-in, and overexpression, provide powerful tools to dissect these pathways. EDITGENE offers comprehensive services to support your MAP kinase research, from custom cell model generation to high-throughput screening and bioinformatics analysis.
References
- 1. Folgueira C et al.. 2024. Remodeling p38 signaling in muscle controls locomotor activity via IL-15.. Sci Adv 10(33):eadn5993 PMID: 39141732
- 2. Osman AA et al.. 2000. Regulation of MAP kinase pathway activity in vivo in human skeletal muscle.. Am J Physiol Endocrinol Metab 278(6):E992-9 PMID: 10827000
- 3. ter Haar E. 2003. Activating MAP KAP kinase 2.. Structure 11(6):611-2 PMID: 12791249
- 4. Owens DM et al.. 2007. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases.. Oncogene 26(22):3203-13 PMID: 17496916
- 5. Xu Q et al.. 2003. The PI 3-kinase-Rac-p38 MAP kinase pathway is involved in the formation of signet-ring cell carcinoma.. Oncogene 22(36):5537-44 PMID: 12944900
- 6. Tatebayashi K et al.. 2020. Osmostress enhances activating phosphorylation of Hog1 MAP kinase by mono-phosphorylated Pbs2 MAP2K.. EMBO J 39(5):e103444 PMID: 32011004
- 7. Salmeron A et al.. 1996. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase.. EMBO J 15(4):817-26 PMID: 8631303
- 8. Ghatan S et al.. 2000. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons.. J Cell Biol 150(2):335-47 PMID: 10908576
